/assets/images/provider/photos/2775922.jpeg)
Tirzepatide is the active ingredient in both Mounjaro and Zepbound. These are prescription brands with different treatment indications. The shared ingredient does not mean that you should combine them or switch between products without instructions.
Having diabetes does not automatically rule someone out of Zepbound’s weight-management indication. Eligibility depends on the specific condition and current product labeling.
Both products can cause gastrointestinal symptoms and have important warnings and contraindications. Discuss prior pancreatitis, gallbladder problems, severe stomach-emptying problems, pregnancy plans, and personal or family history of medullary thyroid cancer or MEN2. Other diabetes medicines and oral contraception may require specific planning. Review the full medication guide with the prescribing team.
Do not combine tirzepatide products or add another GLP-1 medicine on your own. Trial averages are not a prediction of your result, and one person’s experience with nausea does not determine another’s tolerability.
Prevention Clinics can discuss these questions during a weight-management evaluation or diabetes follow-up. Bring current prescriptions and prior treatment history so the decision reflects your needs.
Prevention Clinics offers adult primary care and medical weight management in Clifton and Maywood, New Jersey. Call 973-777-3711 for Clifton or 201-488-2111 for Maywood, or send a message through the website’s Tebra widget. The office can confirm the right appointment and location. For an emergency, call 911.
Updated November 15, 2026. Educational information; recommendations depend on your individual medical history.